ANGO vs NUE · rev $292.5M vs P/E 25, rev $7.08B
AngioDynamics Inc (ANGO) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
ANGO currently screens at market cap $378.5M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the ANGO and NUE stock pages for the full models.
Not investment advice.